| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
|---|
| 03/17/2005 | WO2005023841A1 Novel method for the synthesis of perindopril and the pharmaceutically-acceptable salts thereof |
| 03/17/2005 | WO2005023838A1 Process for the manufacture of an enantiopure compound |
| 03/17/2005 | WO2005023755A1 Novel method for synthesizing esters of n-[(s)-1-carboxybutyl]-(s)-alanine and use thereof for synthesizing perindopril |
| 03/17/2005 | WO2003051835A3 Methods and compositions for the inhibition of viral release |
| 03/17/2005 | US20050059800 Process and intermediates for the preparation of (1R,2S,5S)-3-azabicyclo[3,1,0]hexane-2-carboxamide, N-[3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl]-3-[(2S)-2-[[[1,1-dimethylethyl]amino]carbonylamino]-3,3-dimethyl-1-oxobutyl]-6,6-dimethyl |
| 03/17/2005 | US20050059699 N-acylated lipophilic amino acid derivatives |
| 03/17/2005 | US20050059609 New alpha crystalline form of perindopril tert-butylamine salt |
| 03/17/2005 | US20050059599 Elastin peptide analogs and uses thereof |
| 03/17/2005 | US20050059585 Methionine aminopeptidase-2 inhibitors and methods of use thereof |
| 03/17/2005 | US20050059058 Oligonucleotide sequences coding integral membrane proteins (ZIPA) for use as tool in identifying bactericidal agents; microbiocides; drug screening |
| 03/17/2005 | US20050058993 Method and device for detecting feline immunodeficiency virus |
| 03/17/2005 | US20050058992 Method and device for detecting feline immunodeficiency virus |
| 03/16/2005 | EP1514112A2 Method for isolating an allosteric effector of a receptor |
| 03/16/2005 | EP1513868A1 Process for the production of lisinopril |
| 03/16/2005 | EP1513842A1 Substituted hexahydropyrrolo (1,2-a)pyrazines, octahydropyrido(1,2-a)pyrazines and decahydropyrazino(1,2-a)azepines |
| 03/16/2005 | EP1513814A1 Novel piperidine compound |
| 03/16/2005 | EP1513811A1 Non-peptidic brs-3 agonists |
| 03/16/2005 | EP1353929B1 Streptogramin derivatives preparation thereof and compositions containing same |
| 03/16/2005 | EP1003775B1 Hepatitis c inhibitor peptides |
| 03/16/2005 | EP0869966B1 Prodrugs of thrombin inhibitors |
| 03/15/2005 | US6867284 Fluorinated oligopeptides especially those having 4,4-difluoro- 2-amino butyric acid at the C terminus |
| 03/15/2005 | US6867208 Vitronectin receptor antagonists, their preparation and their use |
| 03/15/2005 | US6867202 Treatment of insulin resistance |
| 03/15/2005 | US6867192 Inhibiting eosinophil infiltration into lungs; such as 2-((-2-((2-(2-Benzoylphenoxy)acetyl)amino)-4-methylpentanoyl)-amino)-3-(4 -(((4-((2-phenylacetyl)amino)-1-piperidinyl)-carbonyl)oxy)phenyl)propanoic acid |
| 03/15/2005 | US6867185 Inhibitors of hepatitis C virus |
| 03/15/2005 | CA2255659C Neuroactive peptides |
| 03/10/2005 | WO2005021584A2 Novel peptidomimetic ns3-serine protease inhibitors of hepatitis c virus |
| 03/10/2005 | WO2005021577A2 Novel plant glycine and histidinie-rich metal-binding protein family and uses thereof |
| 03/10/2005 | WO2005021494A2 D-amino acid peptides |
| 03/10/2005 | WO2005021487A1 Cathepsin inhibitors |
| 03/10/2005 | US20050054719 Dimeric compounds and their use as anti-viral agents |
| 03/10/2005 | US20050054581 Somatostatin antagonists and agonists that act at the sst subtype 2 receptor |
| 03/10/2005 | US20050054580 Methods for production of the oxidized glutathione composite with cis-diamminedichloroplatinum and pharmaceutical compositions based thereof regulating metabolism, proliferation, differentiation and apoptotic mechanisms for normal and transformed cells |
| 03/10/2005 | US20050054579 New crystalline forms |
| 03/10/2005 | US20050054578 Topical cosmetic which increases elasticity of skin; low molecular weight peptide |
| 03/10/2005 | US20050054562 Gastrointestinal disorders; antiulcer agents; pancreatitis; antidiabetic agents |
| 03/10/2005 | US20050054559 Compounds for sustained release of orally delivered drugs |
| 03/10/2005 | US20050054067 Process for producing dipeptide,l-amino acid amide hydrolase to be used therein and process for producing l-amino acid amide hydrolase |
| 03/10/2005 | CA2536570A1 Novel peptidomimetic ns3-serine protease inhibitors of hepatitis c virus |
| 03/10/2005 | CA2535366A1 Cathepsin inhibitors |
| 03/10/2005 | CA2529027A1 D-amino acid peptides |
| 03/09/2005 | EP1512692A2 Novel inhibitors of prenylated pyrophosphate consuming enzymes |
| 03/09/2005 | EP1512397A1 O-substituted hydroxyaryl derivatives |
| 03/09/2005 | EP1511763A2 Intracellular delivery of biological effectors |
| 03/09/2005 | EP1511760A2 Carboxy protection strategies for acidic c-terminal amino acids in chemical ligation of oligopeptides |
| 03/09/2005 | EP1511491A1 Derivatives of azepine and thiazepan as interleukin converting enzyme inhibitors |
| 03/09/2005 | EP0944645B1 INHIBITORS OF INTERLEUKIN-1beta CONVERTING ENZYME |
| 03/09/2005 | EP0779076B1 Peptide, a method of obtaining it and a pharmaceutical compound based on it |
| 03/09/2005 | CN1192036C Novel aspartyl dipeptide ester derivatives and sweeteners |
| 03/09/2005 | CN1192035C Inhibitors of interleukin-1'beta' converting enzyme |
| 03/09/2005 | CN1192020C Antidiabetic agents |
| 03/08/2005 | US6864357 Process for the preparation of peptides |
| 03/08/2005 | US6864290 Statine derivatives for the treatment of Alzheimer's disease |
| 03/08/2005 | US6864250 N-acylated lipophilic amino acid derivatives |
| 03/08/2005 | US6864249 Pharmaceutical compositions containing them are of the class of thrombin inhibitors which are useful as anticoagulants. |
| 03/08/2005 | US6864240 Dipeptide inhibitors of β-secretase |
| 03/08/2005 | US6864082 Modified viral surface proteins for binding to extracellular matrix components |
| 03/03/2005 | WO2005019265A1 Improved method of purifying tfpi and tfpi analogs |
| 03/03/2005 | WO2005019200A2 Aryl piperidine derivatives as vla-1 integrin antagonists and uses thereof |
| 03/03/2005 | WO2005018575A2 Estrogen receptor modulators and uses thereof |
| 03/03/2005 | WO2005018549A2 Methods and compositions for tissue repair |
| 03/03/2005 | WO2005000285A3 METHODS OF TREATING NON-INFLAMMATORY GASTROINTESTINAL TRACT DISORDERS USING Cav2.2 SUBUNIT CALCIUM CHANNEL MODULATORS |
| 03/03/2005 | WO2004069182A3 Active immunization to generate antibodies to soluble a-beta |
| 03/03/2005 | WO2003099315A8 A pharmaceutical composition comprising a retro-iverso isomer peptide |
| 03/03/2005 | US20050049406 Isotopically coded affinity markers 3 |
| 03/03/2005 | US20050049234 Cyclic lactams comprising three amino acids and a tether chain to control the overall shape of the macromolecule; beta-turn mimetics to explore conformationally restricted structures; proteolytic enzyme resistance (nonhydrolyzing); cell penetration; anticoagulants; anticarcinogenic agents |
| 03/03/2005 | US20050049187 Reacting macrocyclic amide compound with hydroxy naphthalene or hydroxy quinoline derivative in a polar non-protic organic solvent in the presence of an organic or inorganic base |
| 03/03/2005 | US20050047999 Matrix metalloproteinase inhibitors |
| 03/03/2005 | CA2536946A1 Estrogen receptor modulators and uses thereof |
| 03/03/2005 | CA2535562A1 Improved method of purifying tfpi and tfpi analogs |
| 03/02/2005 | EP1509769A2 Method of screening groups of radioactive molecules and applications thereof |
| 03/02/2005 | EP1509609A1 Protein hydrolysate rich in tripeptides |
| 03/02/2005 | EP1509301A1 Production of crystalline materials by using high intensity ultrasound |
| 03/02/2005 | EP1509300A1 Production of crystalline materials by using high intensity ultrasound |
| 03/02/2005 | EP1172432B1 Perfume precursor compositions and method for expressing perfume components |
| 03/02/2005 | CN1191273C Long lasting insulinotropic peptides |
| 03/02/2005 | CN1191272C Conjugates of lipophilic moieties and fragments of vasoactive intestinal peptide (VIP) |
| 03/01/2005 | US6861558 Alzheimer's disease |
| 03/01/2005 | US6861539 For inhibiting human immunodeficiency virus protease |
| 03/01/2005 | US6861409 Compounds for use in the dtreatment of growth metabolic disorders |
| 03/01/2005 | US6861043 Cascade polymer complexes, process for their production and pharmaceutical agents containing said complexes |
| 02/24/2005 | WO2005017163A2 Phenotypic knockout of cell-surface proteins |
| 02/24/2005 | WO2005016959A1 Biologically active peptides comprising phenylalanyl-glutamate (fe) and phenylalanyl-glutamyl-glutamate (fee) |
| 02/24/2005 | WO2005016958A2 Compounds for treating tumors |
| 02/24/2005 | WO2005016955A2 Nogo receptor antagonists |
| 02/24/2005 | WO2005016340A1 Furanone derivatives |
| 02/24/2005 | WO2005016283A2 Peptides for enhanced cell attachment and growth |
| 02/24/2005 | WO2005016280A2 Orally administered small peptides synergize statin activity |
| 02/24/2005 | WO2005000872A3 Collagen mimics |
| 02/24/2005 | WO2004113363A3 Dipeptide transglutaminase inhibitors and methods of using the same |
| 02/24/2005 | WO2004104031A3 Modified antiviral peptides with increased activity and cell membrane affinity |
| 02/24/2005 | WO2004101762A3 Detection and treatment of cancers of the colon |
| 02/24/2005 | WO2003018758A3 Reagents and methods for smooth muscle therapies |
| 02/24/2005 | US20050043538 Peptide beta-strand mimics based on 1,2-dihydro-3(6H)-pyridinone |
| 02/24/2005 | US20050043509 Peptoid compounds |
| 02/24/2005 | US20050043313 1-(phenylaminocarbonylmethyl)-3-alkylamino-5,6-disubstituted-2-pyazinones; serine protease inhibitors; anticoagulants; coronary artery and cerebrovascular diseases |
| 02/24/2005 | US20050043246 Acyclovir-peptide analogs |
| 02/24/2005 | US20050042602 Monitoring immunologic, Hematologic and inflammatory diseases |
| 02/24/2005 | CA2535007A1 Nogo receptor antagonists |
| 02/24/2005 | CA2534676A1 Orally administered small peptides synergize statin activity |